RA patients with myopenia showed a lower level of serum myostatin at the baseline when compared with those who did not have myopenia (3004 ± 1640 ng/mL vs. 3428 ± 1689 ng/mL, p = 0.013) [62] (Table 3). This evidence concerns the gene MSTN and rheumatoid arthritis.